On one hand, it activates hypoxia-inducible factor-1α (HIF-1α), thereby transcriptionally up-regulating the expression of programmed death ligand 1 (PD-L1) on tumor cells, promoting immune escape of tumor cells. This evidence concerns the gene HIF1A and neoplasm.